Prof. Dr. med. Holger Bronger

gynecology, tumor immunology and immunotherapy of breast and ovarian cancer

User Score	Experience	Rating	Price Range	Publications	Media Files	Online Consultations
97%	19 years	9.6/10	$$$$	30	2	Yes

Overview

Country, City

Germany, Munich

Health facility

University Hospital Rechts der Isar Munich

Medical unit

Department of gynaecology, obstetrics, and mammology

About the doctor

Prof. Dr. med. Holger Bronger is an esteemed gynecologist who specializes in tumor immunology and breast and ovarian cancer immunotherapy. With over two decades of experience, he has made remarkable contributions in the field, focusing on lymphocyte-recruiting chemokines and immune intervention in various cancers. Dr. Bronger's extensive CV includes prestigious awards and numerous scientific publications highlighting his expertise in personalized cancer treatment. As Head of the Gynecological Cancer Center at the Technical University of Munich and Deputy Director of the Department of Gynaecology, Dr. Bronger leads groundbreaking research projects focusing on therapeutic targets and resistance mechanisms in ovarian cancer. His innovative work on proteolytic degradation and immune checkpoint inhibitors in cancer treatment showcases his commitment to advancing patient care through cutting-edge research. With a proven track record of excellence, Dr. Bronger is at the forefront of gynecological oncology, offering hope and personalized solutions to his patients.

Gallery

Resume

CV (Curriculum Vitae)

Education

1999-2006 Studied human medicine in Aachen, Heidelberg, Basel and Indianapolis
2004-2007 Doctorate "Expression and localization of export pumps of the ABCC family and of uptake transporters for organic anions in human gliomas". Department of Tumor Biochemistry (Prof. Dr. D. Keppler), German Cancer Research Center (DKFZ) Heidelberg, Grade: summa cum laude
2017 Habilitation in Gynecology and Obstetrics, "Regulation and clinical significance of lymphocyte-recruiting chemokines in breast and ovarian cancer" (TU Munich)

Experience

2007-2008 Assistant Physician at the Department of Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf (Prof. Dr. D. Häussinger)
2008-2014 Assistant physician at the Department of Gynecology and Gynaecology, Technical University of Munich (Prof. Dr. M. Kiechle)
2008-2009 Research rotation Clinical Research Group of the Gynaecological Clinic, TU Munich (Prof. Dr. Dr. M. Schmitt)
2011 Establishment and management of the Gynecological Tumor Immunology Working Group
2014 Specialist in gynecology and obstetrics
2015 Senior physician, operative gynecology
2018 Senior staff physician
2020 Senior Consultant at the Gynaecological Clinic, Technical University of Munich
2020 Deputy spokesperson of the project group "Malignant Ovarian Tumors" of the Tumor Center Munich
2020 Head of the Gynecological Cancer Center at the Technical University of Munich
2020 Deputy Director of the Department of Gynaecology, Technical University of Munich
2022 Call for a W3 professorship in Gynecology at the University of Halle ( primo loco )
2022 Spokesperson of the Ovarian Cancer Study Group of the Bavarian Center for Cancer Research (BZKF)
Head of the Gynecological Cancer Center at the Technical University of Munich
Head of Operative Gynecology, (minimally invasive) Tumor Surgery and Robotic Surgery at the Klinikum Rechts der Isar of the Technical University of Munich

Awards & Memberships

2007 Doctorate with distinction (summa cum laude), DKFZ Heidelberg
2012 Research Award of the DGGG
2014 BGGF Science Prize
2014 Young Investigator Best Presentation Award, EORTC Pathobiology Group
2015 Wilhelm Sander Prize
2015 Lecture Award, Translational Research Commission of the AGO (AGO TraFo)
2016 Prize for the best presentation, AGO TraFo (senior author, supervisor)
2016 Lecture Award of the DGGG (61st Congress)
2017 Prize for the best poster, AGO TraFo (senior author, supervisor)
2017 Prize of the German Society for Senology (Best Abstract), XXV Conference of German-speaking University Professors in Gynecology and Obstetrics
2018 AGO Research Prize
2018 BGGF Science Prize (senior author, supervisor)
2019 Prize for the best presentation, AGO TraFo (senior author, supervisor)
2019 Prize for the best poster, AGO TraFo (senior author, supervisor)
2020 Lecture Award of the DGGG (63rd Congress)
2020 Faculty member of the German Consortium for Translational Cancer Research (DKTK)
2011-2014 Wilhelm Sander Foundation: Expression, function, and clinical significance of the chemokines CXCL9 and CXCL10 and their receptor CXCR3 in human breast cancer (Bronger / Schmitt / Specht / Ulm, 2011.006.1)
2014-2017 Wilhelm Sander Foundation: Improving anti-HER2 therapy for breast cancer by increasing CXCL9-mediated lymphocyte infiltration (Bronger / Schmitt / Avril, 2011.006.2)
2014-2017 German Research Foundation (DFG): Importance of the CXCR3 chemokine system for immune intervention in ovarian cancer (BR 4733/1‑1)
2017-2019 Walter Schulz Foundation, Project: Dipeptidylpeptidase IV (DPP4) as a new therapeutic target in ovarian cancer (Bronger)
2017-2021 German Research Foundation (DFG), Project: The role of CX3CL1 in targeted immunotherapy of HER2-positive breast cancer (BR 4733/2-1, with PD Dr. Anja K. Wege, University of Regensburg)
2018-2021 German Research Foundation (DFG), Project: Importance of the CXCR3 receptor for tumor progression in ovarian cancer (BR 4733/1-3)
2020-2022 German Research Foundation (DFG), Project: Kallikrein-related peptidases (KLKs) as a new target structure for improving immune intervention in ovarian cancer (BR 4733/3-1, with Prof. Dr. Viktor Magdolen, Department of Gynecology)
2020-2022 Wilhelm Sander Foundation, Project: Proteolytic chemokine degradation as a new resistance mechanism against PARP inhibitors in ovarian cancer (Bronger, 2019.085.1)
2020-2023 German Research Foundation (DFG), Project: Therapeutic synergism of PARP and DPP4 inhibition in triple-negative breast cancer (BR 4733/4-1)
2022 Wilhelm Sander Foundation, Project: KLK-mediated gene expression as a novel therapy resistance mechanism in ovarian cancer (2021.106.1, with Prof. Viktor Magdolen, Department of Gynecology and Obstetrics)
2023 German Cancer Aid, Project: Resistance to immune checkpoint inhibitors in ovarian cancer due to proteolytic chemokine cleavage (70115411)